[1]
O. Y. Voskoboynik, O. V. Karpenko, S. I. Kovalenko, G. G. Berest, V. V. Ivchuk, and V. M. Shvets, “The structural optimization of [(2-R-quinazolin-4-ylidene)hydrazono]carboxylic acids and esters – approach for creating a new class of compounds with the anticancer activity”, J. Org. Pharm. Chem., vol. 12, no. 4(48), pp. 3–20, Dec. 2014.